124 related articles for article (PubMed ID: 38052280)
1. pH-sensitive niosomes for ATRA delivery: A promising approach to inhibit Pin1 in high-grade serous ovarian cancer.
Giuli MV; Hanieh PN; Forte J; Fabiano MG; Mancusi A; Natiello B; Rinaldi F; Del Favero E; Ammendolia MG; Marianecci C; Checquolo S; Carafa M
Int J Pharm; 2024 Jan; 649():123672. PubMed ID: 38052280
[TBL] [Abstract][Full Text] [Related]
2. A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways.
Yang D; Luo W; Wang J; Zheng M; Liao XH; Zhang N; Lu W; Wang L; Chen AZ; Wu WG; Liu H; Wang SB; Zhou XZ; Lu KP
J Control Release; 2018 Jan; 269():405-422. PubMed ID: 29170140
[TBL] [Abstract][Full Text] [Related]
3. Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer.
Russo Spena C; De Stefano L; Palazzolo S; Salis B; Granchi C; Minutolo F; Tuccinardi T; Fratamico R; Crotti S; D'Aronco S; Agostini M; Corona G; Caligiuri I; Canzonieri V; Rizzolio F
J Control Release; 2018 Jul; 281():1-10. PubMed ID: 29746956
[TBL] [Abstract][Full Text] [Related]
4. Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways.
Lian X; Lin YM; Kozono S; Herbert MK; Li X; Yuan X; Guo J; Guo Y; Tang M; Lin J; Huang Y; Wang B; Qiu C; Tsai CY; Xie J; Gao ZJ; Wu Y; Liu H; Zhou XZ; Lu KP; Chen Y
J Hematol Oncol; 2018 May; 11(1):73. PubMed ID: 29848341
[TBL] [Abstract][Full Text] [Related]
5. Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways.
Liao XH; Zhang AL; Zheng M; Li MQ; Chen CP; Xu H; Chu QS; Yang D; Lu W; Tsai TF; Liu H; Zhou XZ; Lu KP
Sci Rep; 2017 Mar; 7():43639. PubMed ID: 28262728
[TBL] [Abstract][Full Text] [Related]
6. Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines.
Losi L; Lauriola A; Tazzioli E; Gozzi G; Scurani L; D'Arca D; Benhattar J
J Ovarian Res; 2019 Jul; 12(1):62. PubMed ID: 31291979
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer.
Lokman NA; Ho R; Gunasegaran K; Bonner WM; Oehler MK; Ricciardelli C
J Exp Clin Cancer Res; 2019 Jan; 38(1):10. PubMed ID: 30621740
[TBL] [Abstract][Full Text] [Related]
8. A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer.
Narvekar M; Xue HY; Tran NT; Mikhael M; Wong HL
Eur J Pharm Biopharm; 2014 Sep; 88(1):226-37. PubMed ID: 24816129
[TBL] [Abstract][Full Text] [Related]
9. All-Trans Retinoic Acid and Doxorubicin Delivery by Folic Acid Modified Polymeric Micelles for the Modulation of Pin1-Mediated DOX-Induced Breast Cancer Stemness and Metastasis.
Liu Y; Yu F; Dai S; Meng T; Zhu Y; Qiu G; Wen L; Zhou X; Yuan H; Hu F
Mol Pharm; 2021 Nov; 18(11):3966-3978. PubMed ID: 34579532
[TBL] [Abstract][Full Text] [Related]
10. Novel pH-sensitive nanoparticles based on prodrug strategy to delivery All-Trans Retinoic Acid for breast cancer.
Li W; Gong H; Fu Y; Sun J; Wang Y
Colloids Surf B Biointerfaces; 2022 Nov; 219():112838. PubMed ID: 36148708
[TBL] [Abstract][Full Text] [Related]
11. pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all-
Zhang Y; Peng L; Chu J; Zhang M; Sun L; Zhong B; Wu Q
Int J Nanomedicine; 2018; 13():6499-6515. PubMed ID: 30410335
[TBL] [Abstract][Full Text] [Related]
12. Targeting Pin1 by All-Trans Retinoic Acid (ATRA) Overcomes Tamoxifen Resistance in Breast Cancer via Multifactorial Mechanisms.
Huang S; Chen Y; Liang ZM; Li NN; Liu Y; Zhu Y; Liao D; Zhou XZ; Lu KP; Yao Y; Luo ML
Front Cell Dev Biol; 2019; 7():322. PubMed ID: 31867329
[TBL] [Abstract][Full Text] [Related]
13. Liposome nano-formulation with cationic polar lipid DOTAP and cholesterol as a suitable pH-responsive carrier for molecular therapeutic drug (all-trans retinoic acid) delivery to lung cancer cells.
Grace VMB; Wilson DD; Guruvayoorappan C; Danisha JP; Bonati L
IET Nanobiotechnol; 2021 Jun; 15(4):380-390. PubMed ID: 34694713
[TBL] [Abstract][Full Text] [Related]
14. Insulin receptor substrate-1 is an important mediator of ovarian cancer cell growth suppression by all-trans retinoic acid.
Ravikumar S; Perez-Liz G; Del Vale L; Soprano DR; Soprano KJ
Cancer Res; 2007 Oct; 67(19):9266-75. PubMed ID: 17909034
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.
Zheng M; Xu H; Liao XH; Chen CP; Zhang AL; Lu W; Wang L; Yang D; Wang J; Liu H; Zhou XZ; Lu KP
Oncotarget; 2017 May; 8(18):29771-29784. PubMed ID: 28404959
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha.
Gianni' M; Boldetti A; Guarnaccia V; Rambaldi A; Parrella E; Raska I; Rochette-Egly C; Del Sal G; Rustighi A; Terao M; Garattini E
Cancer Res; 2009 Feb; 69(3):1016-26. PubMed ID: 19155306
[TBL] [Abstract][Full Text] [Related]
17. Nanocarrier of Pin1 inhibitor based on supercritical fluid technology inhibits cancer metastasis by blocking multiple signaling pathways.
Zhang F; Zhang A; Xie Y; Wen H; Kankala RK; Huang J; Zhang A; Wang Q; Chen B; Dong H; Guo Z; Chen A; Yang D
Regen Biomater; 2023; 10():rbad014. PubMed ID: 36915713
[TBL] [Abstract][Full Text] [Related]
18. Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies.
Wu W; Xue X; Chen Y; Zheng N; Wang J
Pharmacol Res; 2022 Oct; 184():106456. PubMed ID: 36116709
[TBL] [Abstract][Full Text] [Related]
19. The Optimized Formulation of Tamoxifen-Loaded Niosomes Efficiently Induced Apoptosis and Cell Cycle Arrest in Breast Cancer Cells.
Akbarzadeh I; Farid M; Javidfar M; Zabet N; Shokoohian B; Arki MK; Shpichka A; Noorbazargan H; Aghdaei HA; Hossein-Khannazer N; Timashev P; Makvandi P; Vosough M
AAPS PharmSciTech; 2022 Jan; 23(1):57. PubMed ID: 35048234
[TBL] [Abstract][Full Text] [Related]
20. PIN1 and CDK1 cooperatively govern pVHL stability and suppressive functions.
Chen J; Li M; Liu Y; Guan T; Yang X; Wen Y; Zhu Y; Xiao Z; Shen X; Zhang H; Tang H; Liu T
Cell Death Differ; 2023 Apr; 30(4):1082-1095. PubMed ID: 36813923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
